T
ech
CN
library_books
Mobile
library_books
Laptop/Pc
library_books
Smart Home
library_books
Audio
library_books
Games
Lastnews
Topics
Trending
News
Best Pick
Reviews
How To Do
Search ...
Last
news
G7: MERMEC urges EU to prioritise the ERTMS railway signalling system
...
Pacific Green Achieves Planning Consent for its Limestone Coast, South Australia, 1.5GWh Battery Energy Parks
...
Andan Foundation Announces Award for Innovation in Refugee Inclusion in Collaboration with the Massachusetts Institute of Technology’s MIT Solve
...
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis
Notified -...
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis
...
Accruent Sets New Standard in Workplace Space Optimization with Launch of Accruent Space Intelligence™
...
Marex Opens New Zealand Office
...
Acronis True Image Returns: Reintroducing Acronis' Trusted Home and Office Cyber Protection Solution
...
1
...
405
406
407
408
409
410
411
412
413
...
996
menu
TechCN
person
menu